Sumithra J. Mandrekar

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation

Richard M. Stone, Sumithra J. Mandrekar, Ben L. Sanford et al. · New England Journal of Medicine · 2017 · 2.2K citations · Full text

Medicine, Molecular Medicine, Pharmacotherapy +16

RECIST 1.1—Update and clarification: From the RECIST committee

Lawrence H. Schwartz, Saskia Litière, Elisabeth G.E. de Vries et al. · European Journal of Cancer · 2016 · 1.9K citations

Agriculture, Public Policy, Separation Of Powers +3

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

Jennifer A. Woyach, Amy S. Ruppert, Nyla A. Heerema et al. · New England Journal of Medicine · 2018 · 952 citations · Full text

Medicine, Immunology, Oncology +10

CT Screening for Lung Cancer: Five-year Prospective Experience

Stephen J. Swensen, James R. Jett, Thomas E. Hartman et al. · Radiology · 2005 · 639 citations

Medicine, Oncology, Radiology +14

Clinical Trial Designs for Predictive Biomarker Validation: Theoretical Considerations and Practical Challenges

Sumithra J. Mandrekar, Daniel J. Sargent · Journal of Clinical Oncology · 2009 · 396 citations · Full text

Medicine, Biostatistics, Oncology +17